Table 1.
Group | WBC (×103/µL) | RBC (×106/µL) | HGB (g/dL) | HCT (%) | MCV (fL) | MCH (pg) | MCHC (g/dL) | PLT (×103/µL) |
---|---|---|---|---|---|---|---|---|
Control | 9.53 ± 1.066 | 10.27 ± 1.21 | 15.45 ± 2.03 | 51.78 ± 7.51 | 50.3 ± 1.67 | 15.05 ± 0.98 | 29.93 ± 1.70 | 942.5 ± 252.6 |
5-FU | 3.42 ± 1.00** | 9.03 ± 0.51 | 14.58 ± 0.68 | 45 ± 2.70 | 49.82 ± 0.36 | 16.16 ± 0.61 | 32.44 ± 1.24 | 416.6 ± 54.2 |
5-FU + GMI | 3.7 ± 0.53** | 9.48 ± 2.20 | 15.675 ± 2.53 | 47.05 ± 11.46 | 49.6 ± 0.88 | 16.6 ± 2.04* | 33.5 ± 4.88* | 379.5 ± 138.1 |
Abbreviations: 5-FU, 5-fluorouracil; GMI, Ganoderma microsporum immunomodulatory protein; WBC, white blood cell; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin content; MCHC, mean corpuscular hemoglobin; PLT, platelets.
P < .01, **P < .01 versus the control group. Data presented are means ± SD.